Circulating endothelial progenitor cells and cardiovascular outcomes.

By N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Böhm, G. Nickenig. New England Journal of Medicine, 2005

2,130 citations recorded by the source corpus.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/1bc5e2070224ea80dbb05fc84605550ce9c5e315

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. C. Iadecola
2. C. Kevil
3. S. Bir
4. G. Kolluru

Citations in the corpus

• Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing (2012, background): “EPCs act as a surrogate marker of vascular health and indicate cardiovascular risk in healthy persons [87, 240, 241].”
• The pathobiology of vascular dementia (2013, positive): “EPC are reduced by stroke risk factors (Hill et al., 2003) and predict cardiovascular morbidity and mortality (Werner et al., 2005).”
• Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008, background): “Indeed, low levels of EPC predicted the occurrence of cardiovascular events and death in coronary artery disease patients (104).”
• 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, background): “However, current studies on circulating markers of endothelial activity as well as on progenitors of endothelial cells are promising (240) and simpler tests or markers of endothelial dysfunction or damage may become available in the future.”